
LEGEND BIOTECH CORP-ADR
LEGNNASDAQ๐ #1179 by market capEarnings Aug 11 ยท PreUS Equity
$21.83โฒ $1.24 (+5.66%)
Live1hโ
24hโฒ 5.7%
7dโ
14dโ
30dโ
1yโ
๐ฆMarket Cap
$8.45B
Small Cap
๐Revenue Growth (YoY)
+56.4%
High Growth
๐Gross Margin
55.0%
Healthy
๐ตFCF Margin
โ
โ๏ธP/S Ratio
3.4x
Fair
Otter Score
54
Weak
๐
Analyst Ratings
Price
$21.83
Total
19
Raised
0
Lowered
1
Avg PT
$48.33
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-07-28 |
RBC Capital | Reiterated | Outperform | 2026-07-27 |
UBS | Downgraded | Buy โ Neutral | 2026-07-24 |
Morgan Stanley | Reiterated | Overweight | 2026-05-13 |
TD Cowen | Reiterated | Hold | 2026-05-13 |
Barclays | Reiterated | Overweight | 2026-02-04 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-12-17 |
JP Morgan | Reiterated | Overweight | 2025-10-09 |
Truist Securities | Reiterated | Buy | 2025-05-14 |
Guggenheim | Reiterated | Neutral | 2025-03-12 |
Piper Sandler | Reiterated | Overweight | 2024-12-30 |
Scotiabank | Reiterated | Sector Outperform | 2024-08-12 |
BMO Capital | Reiterated | Outperform | 2024-07-03 |
BTIG | Reiterated | Buy | 2023-06-13 |
William Blair | Reiterated | Market Perform โ Perform | 2023-05-25 |
Daiwa Capital | Reiterated | Buy | 2023-05-22 |
Evercore ISI Group | Reiterated | Outperform | 2022-11-02 |
Cowen & Co. | Reiterated | Outperform | 2022-11-01 |
Jefferies | Reiterated | Buy | 2020-07-01 |
One row per institution, most recent rating